← Eichor
Study identifier: NCT04889911 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

Condition: First Episode Psychosis · Youth  ·  Sponsor: John Jay College of Criminal Justice, City University of New York

PhaseNA
Planned participants40
Who can joinAll sexes, 15 Years to 24 Years
Healthy volunteersNo

About this study

The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase treatment engagement. The specific aims of the project are to: 1) adapt NECT to be responsive to the needs and preferences of youth with FEP, and 2) Assess the feasibility, acceptability and preliminary effectiveness of the modified intervention (NECT-YA) combined with coordinated specialty care (CSC) services, compared to CSC services alone, in a small (n = 40) RCT.

This description comes directly from the study's public registry record.

Talk to the study team

Bethany Leonhardt, Psy.D.  ·  317-880-8665  ·  blleonha@iupui.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Eskenazi Health, PARC ProgramIndianapolis, Indiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04889911